Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment

Clinical trial NCT00422981 · COMPLETED

Trial details

NCT number: NCT00422981
Sponsor: Allon Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment, So Stated

Start date: 2007-01-01
Primary completion: 2008-01-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.